Rett Syndrome Research Trust
The Rett Syndrome Research Trust (RSRT) is a US-based nonprofit dedicated to curing Rett syndrome (RTT) that funded, held the IND for, and oversaw a randomized double-blind placebo-controlled crossover trial of oral ketamine in girls aged 6-12 with RTT; the study confirmed safety and tolerability and demonstrated EEG evidence of NMDA receptor target engagement, supporting further trials with longer duration or higher doses.
Academic Research
0 papersPublished Papers
0
Trial Involvement
1
Distinct Focus Topics
0
Latest Publication
Unknown
Foundations & Philanthropy Snapshot
Grant-Making OrganizationsClassification
Private Foundation
Geography
Global
Coverage
Global
Last Verified
Apr 10, 2026
Funding Focus Areas
Support Types
Philanthropy Notes
Auto-backfilled baseline philanthropy profile from existing category tags and website. Manual enrichment recommended for recipient-level details.
Verification
Verified
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement Status
Unknown
Verification Notes
Verified against official RSRT research grant and translational program pages.
Source Evidence
Quick Facts
- Type
- Non-Profit
- HQ
- United States
- Website
- Visit